FILE:MJN/MJN-8K-20091030085652.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): (Exact name of Registrant as Specified in Charter)
October 30, 2009
MEAD JOHNSON NUTRITION COMPANY
Registrants telephone number, including area code: (Former Name or Former Address, if Changed Since Last Report)
(847) 832-2420
Not Applicable
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 - 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 - 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 - 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 - 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On October 30, 2009, Mead Johnson Nutrition Company issued a press release announcing the pricing of an offering pursuant to Rule 144A and Regulation S of $500 million of 3.50% Notes due 2014, $700 million of 4.90% Notes due 2019 and $300 million of 5.90% Notes due 2039.  A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.
The Notes have not been registered under the Securities Act of 1933, as amended (the Securities Act), and may not be offered or sold in the United States absent registration under, or an applicable exemption from, the registration requirements of the Securities Act.  
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit 99.1
Mead Johnson Nutrition Announces Pricing of Notes Offering
GLENVIEW, Ill.--(BUSINESS WIRE)--October 30, 2009--Mead Johnson Nutrition Company (NYSE: MJN) announced today the pricing of a private offering of senior unsecured notes as follows:
$500 million principal amount of 3.50% Notes due 2014 priced at 99.552% of the principal amount,
$700 million principal amount of 4.90% Notes due 2019 priced at 99.649% of the principal amount, and
$300 million principal amount of 5.90% Notes due 2039 priced at 99.973% of the principal amount.
Proceeds from the offering are intended to be used to repay debt owed to a subsidiary of Bristol-Myers Squibb Company. The sale of the notes is expected to close on or about Nov. 5, 2009.
The notes were offered in a transaction exempt from registration pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the Securities Act). The notes have not been registered under the Securities Act, and may not be offered or sold in the United States absent registration under, or an applicable exemption from, the registration requirements of the Securities Act.
This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.
Forward-Looking Statements
Certain disclosures in this news release are forward-looking statements within the federal securities laws concerning Mead Johnsons note offering. These statements, which are identified by words such as expects, intends and believes, involve certain risks and uncertainties that may cause actual results to differ materially from expectations as of the date of this news release. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. These statements are subject to risks and uncertainties, including without limitation, general market conditions, the market for the companys securities, the performance of the companys business and other risks detailed in the companys filings with the Securities and Exchange Commission. There is no assurance that Mead Johnson will complete the sale of the notes.
CONTACT: Mead Johnson Nutrition Company Investors: Kathryn Chieger, 847832-2419 or Media: Christopher Perille, 847832-2178
-
kathryn.chieger@mjn.com
-
chris.perille@mjn.com


